B. Carey
St James's University Hospital
Quality of lifeInternal medicineRadiologyUrologySurgeryMagnetic resonance imagingUltrasoundMedical physicsSexual functionBiopsyProstateInternational Prostate Symptom ScoreBrachytherapyProstate brachytherapyProstate cancerHormone therapyImplantPopulationNuclear medicinePostimplant dosimetryPost implant dosimetryIncidence (epidemiology)Radiation therapyIodineMedicineCohortDosimetryUrinary system
19Publications
12H-index
570Citations
Publications 24
Newest
#1Josh Mason (St James's University Hospital)H-Index: 2
#2Ese Adiotomre (St James's University Hospital)H-Index: 1
Last. Ann Henry (St James's University Hospital)H-Index: 32
view all 5 authors...
Purpose: Evaluate T2 weighted MRI (T2W), diffusion weighted imaging (DWI), and dynamic contrast enhanced MRI (DCE-MRI) for determining areas of prostate cancer recurrence to target biopsy or salvage treatment in patients previously treated with I-125 seed brachytherapy. Material and methods: MRI data from 15 patients, whose primary treatment was I-125 seed brachytherapy and who were subsequently treated with partial gland salvage high-dose-rate brachytherapy were retrospectively analyzed. Two ra...
3 CitationsSource
#1J. MasonH-Index: 6
Last. Ann HenryH-Index: 32
view all 5 authors...
Source
#2Finbar SlevinH-Index: 2
Last. Ann HenryH-Index: 32
view all 11 authors...
Source
#1Ann HenryH-Index: 32
#1A HenryH-Index: 5
Last. David BottomleyH-Index: 20
view all 10 authors...
Source
#1J. MasonH-Index: 6
#2Peter BownesH-Index: 18
Last. Ann HenryH-Index: 32
view all 4 authors...
For HDR prostate brachytherapy treatments of 15 Gy to the whole gland plus focal boost, optimisation to either tumour plus margin (F-PTV) or involved sectors was compared. For 15 patients median F-PTV D90 and V150 were 21.0 Gy and 77.2% for F-PTV optimisation and 19.8 Gy and 75.6% for sector optimisation.
5 CitationsSource
#1Ann Henry (University of Leeds)H-Index: 32
#2Sree Rodda (St James's University Hospital)H-Index: 2
Last. David Bottomley (St James's University Hospital)H-Index: 20
view all 10 authors...
Abstract Aims To examine the relationship between post-implant computed tomography dosimetry and long-term prostate-specific antigen relapse-free survival in patients treated with iodine 125 (I-125) low dose rate prostate brachytherapy as monotherapy and, second, to audit recent practice against Royal College of Radiologists' (RCR) guidelines after the re-introduction of post-implant dosimetry for all patients in our centre. Materials and methods Between March 1995 and September 2007, 2157 conse...
6 CitationsSource
#1Malcolm David MasonH-Index: 91
Last. Ann HenryH-Index: 32
view all 11 authors...
Source
#1Hima Bindu Musunuru (St James's University Hospital)H-Index: 12
#2M. Mason (St James's University Hospital)H-Index: 2
Last. Ann Henry (St James's University Hospital)H-Index: 32
view all 10 authors...
Abstract Aims Prostate brachytherapy may be associated with a lower risk of radiation-induced second primary cancer (SPC) as a significantly smaller volume of normal tissue is irradiated when compared with external beam techniques. Limited data are available as it has been a routine treatment option for less than 20 years. This study identified cases of SPC in patients who underwent I-125 prostate brachytherapy as monotherapy in a single institution. Materials and methods SPC incidence was retri...
17 CitationsSource
#1J. MasonH-Index: 6
#2Bashar Al-QaisiehH-Index: 17
Last. Ann HenryH-Index: 32
view all 8 authors...
Source
#1Nicholas P. Munro (St James's University Hospital)H-Index: 7
#2Bashar Al-Qaisieh (St James's University Hospital)H-Index: 17
Last. Ann Henry (St James's University Hospital)H-Index: 32
view all 8 authors...
Abstract Background and purpose The effect of predominating Gleason grade (3+4 versus 4+3) in Gleason sum score (GS) 7 prostate cancer (PCa) on brachytherapy outcomes is unclear. The 10year experience of permanent brachytherapy monotherapy at a single UK centre for GS 7, intermediate risk (Memorial Sloan-Kettering model), PSA⩽10ng/ml, localised PCa is reported. Materials and methods Between 1995 and 2004, the outcomes of 187 patients with GS 7 PCa (PSA⩽10ng/ml) were analysed from a cohort of 129...
53 CitationsSource